Eye-on-a-Chip Represents New Way to Do Disease Research

 Without some sort of testing platform, research on diseases and their treatments would grind to a halt

Written byUniversity of Pennsylvania
| 3 min read
Register for free to listen to this article
Listen with Speechify
0:00
3:00

A clump of cells in a Petri dish may have the same DNA as their counterparts in the body, but most of the similarities end there. Testing how they respond to new drugs, toxins, or environmental pollutants provides some insight into how cells might behave in the real world, but such tests can’t account for a myriad of factors that come along with the rich, three-dimensional environment they naturally exist within. Animal models provide a closer picture, but come with their own anatomical idiosyncrasies and ethical concerns.

These challenges, however, are preferable to the alternative: exposing humans to chemicals with unknown effects and risk. Without some sort of testing platform, research on diseases and their treatments would grind to a halt.

To continue reading this article, sign up for FREE to
Lab Manager Logo
Membership is FREE and provides you with instant access to eNewsletters, digital publications, article archives, and more.
Add Lab Manager as a preferred source on Google

Add Lab Manager as a preferred Google source to see more of our trusted coverage.

Related Topics

CURRENT ISSUE - January/February 2026

How to Build Trust Into Every Lab Result

Applying the Six Cs Helps Labs Deliver Results Stakeholders Can Rely On

Lab Manager January/February 2026 Cover Image